Stock REGN REGENERON PHARMACEUTICALS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Insiders Regeneron Pharmaceuticals, Inc.

Equities

REGN

US75886F1075

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-05-24 pm EDT 		5-day change 1st Jan Change
985 USD +0.45% Intraday chart for Regeneron Pharmaceuticals, Inc. +0.28% +12.15%
May. 23 Regeneron Pharmaceuticals Says GN7075 Plus Libtayo Shows Anti-Tumor Responses in Microsatellite Stable Colorectal Cancer MT
May. 23 Regeneron Pharmaceuticals, Inc. Announces Positive New Results from an Ongoing Phase 1/2 Trial Evaluating its First-in-Class Costimulatory Bispecific Antibody, REGN7075 CI

Insiders

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Regeneron Pharmaceuticals Insider Sold Shares Worth $1,855,489, According to a Recent SEC Filing
MT
Regeneron Pharmaceuticals Insider Sold Shares Worth $22,355,714, According to a Recent SEC Filing
MT
Regeneron Pharmaceuticals Insider Sold Shares Worth $48,636,545, According to a Recent SEC Filing
MT
Regeneron Pharmaceuticals Insider Sold Shares Worth $35,207,110, According to a Recent SEC Filing
MT
Regeneron Pharmaceuticals Insider Sold Shares Worth $5,531,290, According to a Recent SEC Filing
MT
Regeneron Pharmaceuticals Insider Sold Shares Worth $346,365, According to a Recent SEC Filing
MT
Regeneron Pharmaceuticals Insider Sold Shares Worth $3,387,500, According to a Recent SEC Filing
MT
Regeneron Pharmaceuticals Insider Sold Shares Worth $967,650, According to a Recent SEC Filing
MT
Regeneron Pharmaceuticals Insider Sold Shares Worth $836,280, According to a Recent SEC Filing
MT
Regeneron Pharmaceuticals Insider Sold Shares Worth $4,689,320, According to a Recent SEC Filing
MT
Regeneron Pharmaceuticals Insider Sold Shares Worth $950,000, According to a Recent SEC Filing
MT
Regeneron Pharmaceuticals Insider Sold Shares Worth $950,000, According to a Recent SEC Filing
MT
Regeneron Pharmaceuticals Insider Sold Shares Worth $7,637,954, According to a Recent SEC Filing
MT
Regeneron Pharmaceuticals Insider Sold Shares Worth $934,710, According to a Recent SEC Filing
MT
Regeneron Pharmaceuticals Insider Sold Shares Worth $258,152, According to a Recent SEC Filing
MT
Regeneron Pharmaceuticals Insider Sold Shares Worth $793,093, According to a Recent SEC Filing
MT
Regeneron Pharmaceuticals, Inc. Appoints Jason Pitofsky as Controller, Expects to Occur on February 5, 2024
CI
Regeneron Pharmaceuticals, Inc. Appoints Philip Gregory as Senior Vice President and Head of Regeneron Cell Medicines
CI
Regeneron Pharmaceuticals Insider Sold Shares Worth $2,571,650, According to a Recent SEC Filing
MT
Regeneron Pharmaceuticals Insider Sold Shares Worth $1,005,300, According to a Recent SEC Filing
MT
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. REGN Stock
  4. News Regeneron Pharmaceuticals, Inc.
  5. Insiders